Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1974;43:104-108
© 1974 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BOLOGNESE, R. J.
Right arrow Articles by CORSON, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOLOGNESE, R. J.
Right arrow Articles by CORSON, S. L.

Prostaglandin E2Vaginal Suppository as an Early Second Trimester Abortifacient

RONALD J. BOLOGNESE, MD, FACOG and STEPHEN L. CORSON, MD, FACOG

From the Department of Obstetrics and Gynecology at Pennsylvania Hospital, School of Medicine, University of Pennsylvania. Philadelphia, Pennsylvania

Abstract

Sixty-two normal gestations of 13 to 17 weeks and 1 molar pregnancy were completely or incompletely aborted using prostaglandin E2 as a vaginally administered agent. Average interval-abortion time was 11.9 hours. Side effects were frequent—vomiting and/or diarrhea in 8I%, temperature over 100º F in 61%, headache in 19%—but were not of a serious nature. Comparisons with similar studies show consistent results and suggest that a longer interval between serial doses may prove to be effective.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Obstetricians and Gynecologists.